- Home
- ARCB vs ELVN Comparison
ARCB vs ELVN Comparison
Compare ARCB & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCB | ELVN |
|---|---|---|
| Founded | 1923 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARCB | ELVN |
|---|---|---|
| Price | $122.36 | $41.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $122.75 | $43.40 |
| AVG Volume (30 Days) | 325.4K | ★ 640.9K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.38% | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,657,864,000.00 | N/A |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $5.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.56 | N/A |
| 52 Week Low | $59.43 | $14.79 |
| 52 Week High | $135.10 | $48.53 |
Technical Indicators
Market Signals| Indicator | ARCB | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 49.81 |
| Support Level | $115.28 | $16.84 |
| Resistance Level | $135.10 | $48.53 |
| Average True Range (ATR) | 5.50 | 2.46 |
| MACD | -1.23 | -0.34 |
| Stochastic Oscillator | 50.91 | 34.79 |
Price Performance
Historical ComparisonAbout ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.